Literature DB >> 33636182

ATR activation is regulated by dimerization of ATR activating proteins.

Vaughn Thada1, David Cortez2.   

Abstract

The checkpoint kinase ATR regulates DNA repair, cell cycle progression, and other DNA damage and replication stress responses. ATR signaling is stimulated by an ATR activating protein, and in metazoan cells, there are at least two ATR activators: TOPBP1 and ETAA1. Current evidence indicates TOPBP1 and ETAA1 activate ATR via the same biochemical mechanism, but several aspects of this mechanism remain undefined. For example, ATR and its obligate binding partner ATR interacting protein (ATRIP) form a tetrameric complex consisting of two ATR and two ATRIP molecules, but whether TOPBP1 or ETAA1 dimerization is similarly required for ATR function is unclear. Here, we show that fusion of the TOPBP1 and ETAA1 ATR activation domains (AADs) to dimeric tags makes them more potent activators of ATR in vitro. Furthermore, induced dimerization of both AADs using chemical dimerization of a modified FKBP tag enhances ATR kinase activation and signaling in cells. ETAA1 forms oligomeric complexes mediated by regions of the protein that are predicted to be intrinsically disordered. Induced dimerization of a "mini-ETAA1" protein that contains the AAD and Replication Protein A (RPA) interaction motifs enhances ATR signaling, rescues cellular hypersensitivity to DNA damaging agents, and suppresses micronuclei formation in ETAA1-deficient cells. Together, our results indicate that TOPBP1 and ETAA1 dimerization is important for optimal ATR signaling and genome stability.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATR; ATR activation domain; DNA damage response; ETAA1; RPA; TOPBP1; cell cycle checkpoint; phosphatidylinositol 3-kinase related protein kinase; replication stress response

Year:  2021        PMID: 33636182      PMCID: PMC7994790          DOI: 10.1016/j.jbc.2021.100455

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  The Potential Important Role of Mitochondrial Rieske Iron-Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.

Authors:  Lillian Truong; Yun-Min Zheng; Yong-Xiao Wang
Journal:  Biomedicines       Date:  2022-04-21

2.  MRN-dependent and independent pathways for recruitment of TOPBP1 to DNA double-strand breaks.

Authors:  Katrina Montales; Kenna Ruis; Howard Lindsay; W Matthew Michael
Journal:  PLoS One       Date:  2022-08-02       Impact factor: 3.752

Review 3.  Targeting Replication Stress Response Pathways to Enhance Genotoxic Chemo- and Radiotherapy.

Authors:  Jac A Nickoloff
Journal:  Molecules       Date:  2022-07-25       Impact factor: 4.927

4.  Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.

Authors:  Mirjam E van de Velde; Aniek Uittenboogaard; Wenjian Yang; Erik Bonten; Cheng Cheng; Deqing Pei; Marleen H van den Berg; Inge M van der Sluis; Cor van den Bos; Floor C H Abbink; Marry M van den Heuvel-Eibrink; Heidi Segers; Christophe Chantrain; Jutte van der Werff Ten Bosch; Leen Willems; William E Evans; Gertjan J L Kaspers
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.